Showing results (111-120 of 241) with videos related to

Sort By:
Pageof 25
Oncotarget|June 9, 2016
Intrinsic resistance to PIM kinase inhibition in AML through p38α-mediated feedback activation of mTOR signalingDiede Brunen, María José García-Barchino, Disha Malani, et al.
Journal of Leukocyte Biology|September 10, 2003
Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genesRichard Karlsson, Maria Engström, Maria Jönsson, et al.
Stem Cell Research & Therapy|May 17, 2020
Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cellsXiaojie Xian, Roksana Moraghebi, Henrik Löfvall, et al.
Arthritis Research & Therapy|April 12, 2018
Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processesHenrik Löfvall, Hannah Newbould, Morten A Karsdal, et al.
European Journal of Haematology|February 5, 2017
Forced expression of human macrophage colony-stimulating factor in CD34<sup>+</sup> cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitroCarmen P Montano Almendras, Christian S Thudium, Henrik Löfvall, et al.
Neuroimage. Clinical|December 17, 2025
Mapping brain tumor microstructure: A multimodal study of diffusion MRI, intraoperative fluorescence, and neuropathology in navigated biopsiesElisabeth Klint, Johan Richter, Teresa Nordin, et al.
Cancer Research|May 12, 2025
A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid LeukemiaYingjia Chen, Liye He, Aleksandr Ianevski, et al.
Blood Advances|January 23, 2020
Immune profiles in acute myeloid leukemia bone marrow associate with patient age, T-cell receptor clonality, and survivalOscar Brück, Olli Dufva, Helena Hohtari, et al.
Immunology|April 6, 2011
Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitroCamilla A Lindqvist, Lisa H Christiansson, Ingrid Thörn, et al.
Future Oncology (London, England)|January 20, 2016
Design of the randomized, Phase III, QUAZAR AML Maintenance trial of CC-486 (oral azacitidine) maintenance therapy in acute myeloid leukemiaGail J Roboz, Pau Montesinos, Dominik Selleslag, et al.
Pageof 25